Saccharomyces boulardii and infection due to Giardia lamblia

Scandinavian Journal of Infectious Diseases

Volumn 38, Issue 6-7, 2006, Pages 479-481

  Besirbellioglu, Bulent ^a   Ulcay, Asim ^a   Can, Mehmet ^b   Erdem, Hakan ^a   Tanyuksel, Mehmet ^a   Avci, Ismail Yasar ^a   Araz, Engin ^a   Pahsa, Alaaddin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Department of Cardiology   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; REFLOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FECES ANALYSIS; FEMALE; GIARDIA LAMBLIA; GIARDIASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; SACCHAROMYCES BOULARDII; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; DOUBLE-BLIND METHOD; FEMALE; GIARDIA LAMBLIA; HUMANS; MALE; METRONIDAZOLE; PROBIOTICS; SACCHAROMYCES; STATISTICS, NONPARAMETRIC; YEAST, DRIED;

EID: 33746654149     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540600561769     Document Type: Article

References (15)

1. Hawrelak, J. (2003) Giardiasis: Pathophysiology and management Altern Med Rev, 8, pp. 129-42.
2. Surawicz, CM and Elmer, GW and Speelman, P and McFarland, LV and Chinn, J and van Belle, G. (1989) Prevention of antibiotic-associated diarrhoea by Saccharomyces boulardii: A prospective study Gastroenterology, 96, pp. 981-8.
3. Surawicz, CM and McFarland, LV and Elmer, G and Chinn, J. (1989) Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii Am J Gastroenterol, 84, pp. 1285-7.
4. Czerucka, D and Rampal, P. (2002) Experimental effects of Saccharomyces boulardii on diarrhoeal pathogens Microbes Infect, 4, pp. 733-9.
5. Vanderhoof, JA and Young, RJ. (1998) Use of probiotics in childhood gastrointestinal disorders J Pediatr Gastroenterol Nutr, 27, pp. 323-32.
6. Buts, JP and Bernasconi, P and Vaerman, JP and Dive, C. (1990) Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii Dig Dis Sci, 35, pp. 251-6.
7. Periti, P and Tonelli, F. (2001) Preclinical and clinical pharmacology of biotherapeutic agents: Saccharomyces boulardii J Chemother, 13, pp. 473-93.
8. Meloni, BP and Thompson, RC and Reynoldson, JA and Seville, P. (1990) Albendazole: A more effective antigiardial agent in vitro than metronidazole or tinidazole Trans R Soc Trop Med Hyg, 84, pp. 375-9.
9. Nash, TE and Ohl, CA and Thomas, E and Subramanian, G and Keiser, P and Moore, TA. (2001) Treatment of patients with refractory giardiasis Clin Infect Dis, 33, pp. 22-8.
10. Guillot, CC and Bacallao, EG and Dominguez, MSC and Garcia, MF and Gutierrez, PM. (1995) Effects of Saccharomyces boulardii in children with chronic diarrhoea, especially cases due to giardiasis Rev Mex De Puericultura Y Pediatria, 2, pp. 1-5.
11. Thompson, RC. (2004) The zoonotic significance and molecular epidemiology of Giardia and giardiasis Vet Parasitol, 126, pp. 15-35.
12. Mansour-Ghanaei, F and Dehbashi, N and Yazdanparast, K and Shafaghi, A. (2003) Efficacy of Saccharomyces boulardii with antibiotics in acute amoebiasis World J Gastroenterol, 9, pp. 1832-3.
13. Rigothier, MC and Maccario, J and Gayral, P. (1994) Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro Parasitol Res, 80, pp. 10-5.
14. Jahn, HU and Ullrich, R and Schneider, T and Liehr, RM and Schieferdecker, HL and Holst, H and (1996) Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers Digestion, 57, pp. 95-104.
15. Buts, JP and Bernasconi, P and van Craynest, MP and Maldague, P and De Meyer, R. (1986) Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii Pediatr Res, 20, pp. 192-6.